Successful resection of oesophageal adenocarcinoma 16 years after heart transplantation—a case report  by Eckerström, Filip et al.
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INTRODUCTION:  With  improving  results  of  heart  transplantation  and  subsequently  increasing  survival,
long-term  complications  such  as  neoplastic  malignancies  are  more  often  being  discovered.
PRESENTATION  OF  CASE:  In this  report,  we present  a unique  case  of successful  oesophagus  resection  with
gastric  pull-up,  on  a  heart-transplanted  patient  diagnosed  with  oesophageal  adenocarcinoma.
DISCUSSION:  With  the  growing  number  of  long-term  surviving  heart  transplanted  patients,  the  number
of  neoplasia  in this  patient-group  will  subsequently  grow.  Since  physical  condition  and  quality  of  life
in long-term  surviving  heart  transplanted  patients  is  comparable  to the general  population,  and  since
surgical  treatment  remains  the mainstay  of  treatment  for localised  oesophageal  carcinoma  in non-hearteart transplantation
urgical approach
transplanted  patients,  a larger  subgroup  of  heart  transplanted  patients  will  most  likely  be considered  for
cancer surgery.
CONCLUSION:  Our case  demonstrates  the  possibility  of operating  on  the  heart  transplanted  patient-group,
and  supports  the  option,  that  well-managed  heart transplantation  not  should  be a  limiting  factor,  when
deciding  whether  a patient  is  a candidate  for surgical  intervention  or not.
©  2016  The  Authors.  Published  by  Elsevier  Ltd.  on behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Heart transplantation (HTx) has for some years improved the
uality of life signiﬁcantly in patients with end-stage heart failure.
ith improving results of the procedure and increasing survival
f the HTx-patients, long-term complications such as neoplastic
alignancies are more often being discovered, and becoming an
ssue of concern [1].
Prognosis of most of the solid organ tumours occurring in this
ontext is poor, and neoplasia remains the most frequent non-
raft-related cause of late deaths after HTx [2]. The risk of de novo
alignancies in heart transplant recipients is reported to be rang-
ng from 3 to 25% and has become a signiﬁcant limiting factor for
urther survival in the long-term surviving patients [1]. Interest-
ngly, this is a group of patients that otherwise is comparable to the
eneral population when it comes to physical condition and quality
f life [3].
The mechanism behind the development of neoplasia in this
atient group is poorly understood. The intense immunosup-
ressive therapy in heart transplant recipients may  result in
evelopment of malignancy. Yagdi et al., and Rinaldi et al., demon-
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enmark.
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210-2612/© 2016 The Authors. Published by Elsevier Ltd. on behalf of IJS Publishing 
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strate a signiﬁcant correlation between the patient’s age at time
of transplantation and the risk of malignancies [1,4]. Furthermore,
both studies reveal that a history of smoking has a signiﬁcant asso-
ciation with the development of solid organ malignancy, suggesting
that a possible combination of altered cellular immune response
due to cigarette smoking and pharmacological immunosuppression
are responsible for an accelerated carcinogenic effect. However, just
being a candidate for HTx, is thought to be associated with a higher
risk in the development of neoplasia [2].
Larger surgical interventions and the subsequent survival-rate
in HTx-patients are poorly described. Here we present a case of
successful oesophageal resection with gastric pull-up in an HTx
patient. Our case demonstrates the possibility of operating on the
HTx patient-group. Since an expert surgeon of today has very few
technical limitations, the main challenge in this case was the alto-
gether medical and surgical stress on the body, along with an
acceptable level of quality of life.
2. Presentation of case
In 1998 our patient, a non-smoking Caucasian male, 53 years
old, underwent HTx after a ten-year history of ischemic heart
disease. The HTx operation was  performed at our hospital in
Aarhus, Denmark. After a difﬁcult course at the intensive care post-
operatively, our patient recovered and was  discharged three weeks
following the HTx. The patient received a standard triple immuno-
suppressive regimen consisting of azathioprine, cyclosporine and
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Fig. 1. Positron emission tomography–computed tomography. Arrows demonstra
nd  (B) transverse plane.
rednisolone. Routine follow-up revealed satisfying condition, and
6 years following the HTx-surgery, our patient was still well com-
ensated with a good quality of life.
In April 2014, now 69 years old, with a 16 years history of
Tx, gastroscopic examination following two months of suffering
rom dysphagia revealed a 4.5 cm tumour in cardia/distal sec-
ion of oesophagus. Histological biopsy revealed adenocarcinoma,
3N2M0, spreading to the surrounding blood vessels and ﬁve out
f 14 lymph nodes (Figs. 1 and 2).
Following meticulous cardiologic evaluation of the risk of
urgery, our patient was assessed to be a candidate for cancer
urgery and went through a resection of oesophagus with gas-
ric pull-up and anastomosis placed at the level of the azygos
ein. The procedure was accomplished by abdominal laparoscopy
nd right thoracotomy without signiﬁcant complications peri- or
ost-operatively. Due to our patient’s history of HTx, perioperative
hemotherapy and postoperative radiotherapy was dismissed, and
ur patient was discharged 13 days later on a normal diet.
Monthly routine examinations following the operation revealed
n unchanged cardiac performance with a systolic blood pressure
f 125 mm Hg, good physical performance, and good self-evaluated
uality of life. However, the surgery was not curable, and our
atient died because of his progressive cancer, 10 months following
he surgery, at the age of 70 years.
ig. 2. Post-operative computed tomography. Arrow indicate the gastric-pull up.permetabolic area at the oesophageal/cardia junction through a (A) frontal plane
3. Discussion
Oesophagus and cardia resection with gastric pull-up in an HTx
patient is very rare, and to date only two  other cases like our report
have been described [3,5]. The fact that HTx patients are assessed
as a vulnerable group of patients and the majority consequently
receives palliative care rather than surgery, could eventually be the
explanation for the small number of cases. Our  case supports the
option of aggressive surgical intervention despite previous large-
scale operations, such as HTx. In line with our assessment, Gupta
et al., and von Rahden et al., accentuate the possibility of large-scale
surgical intervention in HTx patients [3,5].
Other cases of large surgical interventions on neoplasia in HTx
patients have been reported. In a previous report, eight HTx patients
with early-stage lung carcinoma went through a successful surgical
resection, reﬂected in a relatively promising median survival of 12
months [2]. However, type of malignancy and extent of the surgical
procedure highly reﬂect survival-rate.
In the case with our patient, naturally we cannot be certain that
the survival rate was increased following surgery compared to a
non-surgical choice. However, the different options were discussed
thoroughly, and since the Department of Oncology advised a strict
no radiation or chemotherapy treatment based on his status as
an HTx patient, surgery was  chosen as the best option. With the
growing number of long-term surviving HTx patients, the number
of neoplasia in HTx patients will subsequently grow. Since physical
condition and quality of life in this patient group is comparable
to the general population, and since surgical treatment remains
the mainstay of treatment for localised oesophageal carcinoma
in non-HTx patients, a larger subgroup of HTx patients will most
likely be considered for cancer surgery [6]. This underlines the
importance of sharing the outcome and experience from large
surgical interventions like that of our case. Provided satisfactory
haemodynamic, well-managed HTx is not a limiting factor at our
institution, when deciding whether a patient is a candidate for
surgical intervention or not.Conﬂict of interests
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